Original Source(s)
Related Content
FDA raises TMB threshold for pembrolizumab
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
-
3 min
Could Wearables Redefine Diagnostics?
Advances in biosensors and manufacturing could bring continuous molecular monitoring into routine care, but clinical validation remains a major challenge
October 23, 2026
-
2 min
What's Next for Prenatal Screening?
Review highlights gaps in understanding of fetal DNA in maternal blood that may be limiting prenatal testing
October 16, 2026
-
3 min